Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...

Robert F. Kennedy Jr., one of President-elect Donald J. Trump’s advisers on health, is taking aim at the agency’s oversight ...

Food and Drug Administration commissioner Robert Califf said he was “disappointed” with the presidential election result and ...

While personally “disappointed” about the election’s outcome, current FDA Commissioner Robert Califf, M.D., has laid out the ...

FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and ...

The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s ...

FDA commissioner Robert Califf’s second term is anticipated to end in 2025, and all eyes are now on who will be the next to take the position after Donald Trump is elected president for the ...

The day after the election, some celebrated Trump's win and RFK Jr.'s potential role as a public health decision-maker. Why?

Many scientists at the federal health agencies await the second Donald Trump administration with dread as well as uncertainty ...

BioNTech said that it is acquiring the Chinese drugmaker Biotheus for $800 million to bolster its cancer strategy. The two ...